Skip to main content
SpringerLink
Log in

Genetic Toxicology Testing

  • Chapter
The Future of Predictive Safety Evaluation

  • 50 Accesses

Abstract

During the 1970s an intensive research effort was devoted to the development of techniques to investigate chemical-induced genetic damage in a variety of cells and organisms. The impetus for this research was provided, in the first place, by the realization that chemicals were capable of producing mutations in mammalian cells that may eventually increase the incidence of heritable disease in man and, secondly, the desire to find quick and inexpensive assays to detect chemicals with carcinogenic potential. Mutations are usually the result of an interaction of the chemicals with DNA, and it was generally accepted that the cellular changes associated with chemical-induced neoplasia were also responses to an interaction with DNA. It is now evident that, although the initial stages of neoplastic transformation probably require a change in DNA structure caused by a mutagenic carcinogen, other carcinogens do not react directly with DNA and exert their effects on other stages of the carcinogenic process, e.g. carcinogen enhancers[1]. Thus most of the current short-term assays for mutagenic and carcinogenic chemicals are based on interaction with DNA resulting in gene mutations, chromosomal aberrations, unscheduled DNA synthesis, etc.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Clayson, DB (1981). Carcinogens and carcinogen enhancers. ICPEMC Working Paper No.2/3. Mutation Res., 86, 217–29

    PubMed  CAS  Google Scholar 

  2. Ames, BN, McCann, J and Yamasaki, E (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutation Res, 31, 347–64

    PubMed  CAS  Google Scholar 

  3. Butterworth, B and Goldberg, L (eds)(1979). Strategies for Short-term Tests for Mutagens and Carcinogens. (West Palm Beach, Florida: CRC Press)

    Google Scholar 

  4. Department of Health and Social Security: Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (1981). Guidelines for the Testing of Chemi¬cals for Mutagenicity. (London: HMSO )

    Google Scholar 

  5. Dean, BJ and Hodges, P (1982). Short-term tests for genotoxicity. In Balls, M, Riddell, RJ and Worden, AN (eds) Animals and Alternatives in Toxicity Testing, pp. 381–409. ( London: Academic Press )

    Google Scholar 

  6. Brustick, D (1980). Principles of Genetic Toxicology. ( New York/London: Plenum Press )

    Google Scholar 

  7. United Kingdom Environmental Mutagen Society (1983). Report of the UKEMS Sub-Committee on Guidelines for Mutagenicity Testing, Part 1. Dean, BJ (ed). (University of Swansea: UKEMS )

    Google Scholar 

  8. United Kingdom Environmental Mutagen Society (1084). Report of the UKEMS Sub-Committee on Guidelines for Mutagenicity Testing, Part 2. Dean, BJ (ed). (University of Swansea: UKEMS )

    Google Scholar 

  9. De Serres, FJ and Ashby, J (eds)(1982). Evaluation of Short-term Tests for Carcinogens. Progress in Mutation Research, Vol.1. (Amsterdam: Elsevier)

    Google Scholar 

  10. Ashby, J, de Serres, FJ, Draper, M, Ishidate, M (Jnr), Margolin, B, Matter, B and Shelby, MD (eds)(1985). Evaluation of Short-term Tests for Carcinogens: Report of the International Program on Chemical Safety Collaborative Study on In Vitro Assays. (Amsterdam: Elsevier)

    Google Scholar 

  11. Brooks, TM and Dean, BJ (1982). Mutagenic activity of 42 coded compounds in the Salmonella /microsome assay with preincubation. In de Serres, FJ and Ashby, J (eds) Evaluation of Short-term Tests for Carcinogens. Progress in Mutation Research, Vol. 1. pp. 261–70. ( Amsterdam: Elsevier )

    Google Scholar 

  12. Venitt, S and Forster, R (1985). Bacterial mutagenicity assays: co-ordinators1 report. In Arlett, CF and Parry, JM (eds) Comparative Genetic Toxicology: The Second UKEMS Collaborative Study. ( London: Macmillan )

    Google Scholar 

  13. Dean, BJ (1985). Summary report on the performace of cytogenetic assays in cultured mammalian cells. In Ashby, J, de Serres, FJ, Draper, M, Ishidate, M (Jnr), Margolin, BH, Matter, BE and Shelby, MD (eds) Evaluation of Short-term Tests for Carcinogens: Report of the International Program on Chemical Safety Collaborative Study on In Vitro Assays, pp. 69–83. ( Amsterdam: Elsevier )

    Google Scholar 

  14. Dean, BJ and Hodson-Walker, G (1979). An in vitro chromosome assay using cultured rat liver cells. Mutation Res, 64, 329–37

    PubMed  CAS  Google Scholar 

  15. Tong, C and Williams, GM (1978). Induction of purine analog-resistant mutants in adult rat liver epithelial lines by metabolic activation-dependant and -independant carcinogens. Mutation Res, 58, 339–52

    Article  CAS  Google Scholar 

  16. Danford, ND (1985). Tests for chromosomal aberrations and aneuploidy in the Chinese hamster fibroblast line CH1-L. In Ashby, J, de Serres, FJ, Draper, M, Ishidate, M (Jnr), Margolin, BH, Matter, BE and Shelby, MD (eds). Evaluation of Short-term Tests for Carcinogens: Report of the International Program on Chemical Safety Collaborative Study on In Vitro Assays, pp. 397–411. ( Amsterdam: Elsevier )

    Google Scholar 

  17. Marquardt, H, Juroki, T, Huberman, E, Selkirk, JK, Heidelberger, C, Grover, PL and Sims, P (1972). Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res, 32, 716–20

    PubMed  CAS  Google Scholar 

  18. DiPaolo, JA, Takano, K and Popescu, NC (1972). Quantitation of chemically induced neoplastic transformation of BALB/3T3 cloned cell lines. Cancer Res, 32, 2686–95

    PubMed  CAS  Google Scholar 

  19. Pienta, RJ, Poiley, JA and Lebhertz, WB (1977). Morphological transformation of early passage golden Syrian hamster embryo cells derived from cryo-preserved primary cultures as a reliable in vitro assay for identifying diverse car-cinogens. Int J Cancer, 19, 642–55

    Article  PubMed  CAS  Google Scholar 

  20. Parry, JM, Parry, EM and Barrett, JC (1981). Tumour promoters induce mitotic aneuploidy in yeast. Nature, 294, 263–65

    Article  PubMed  CAS  Google Scholar 

  21. Tsusui, T, Maizumi, H, McLachlan, JA and Barrett, JC (1983). Aneuploidy-induction and cell transformation by diethylstilbestrol: a possible chromosome mechanism in carcinogens. Cancer Res, 43, 3816–21

    Google Scholar 

  22. Meyer, AL (1983). In vitro transformation assays for chemical carcinogens. Mutation Res, 115, 323–38

    PubMed  CAS  Google Scholar 

  23. Dean, BJ and Hodson-Walker, G (1979). Organ-specific mutations in Chinese hamsters induced by chemical carcinogens. Mutation Res, 64, 407–13

    PubMed  CAS  Google Scholar 

  24. Dean, BJ and Hodson-Walker, G (1979). Organ-specific mutations in Chinese hamsters induced by chemical carcinogens. Mutation Res, 64, 407–13

    PubMed  CAS  Google Scholar 

  25. Purchase, IFH, Richardson, CR, Anderson, D, Paddle, GM and Adams, WGF (1978). Chromosomal analysis in vinyl chloride-exposed workers. Mutation Res, 57, 325–34

    PubMed  CAS  Google Scholar 

  26. Laurent, C, Frederic, J and Marachal, F (1983). Increased sister chromatid exchange frequency in workers exposed to ethylene oxide. Ann Genet, 26, 138–42

    PubMed  CAS  Google Scholar 

  27. Ehrenberg, L, Hiesche, KD, Osterman-Golkar, S and Wennburg, I (1974). Evaluation of genetic risk of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutation Res, 24, 83–103

    Article  PubMed  CAS  Google Scholar 

  28. Osterman-Golkar, S, Ehrenberg, L, Segerback, D and Hallstrom, I (1976). Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutation Res, 34, 1–10

    Article  PubMed  CAS  Google Scholar 

  29. Segerback, D, Calleman, CJ, Ehrenberg, L, Lofroth, G and Osterman-Golkar, S (1978). Evaluation of genetic risks of alkylating agents. IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after treatment of mice with methyl me thane-sulphonate. Mutation Res, 49, 71–82

    Article  PubMed  CAS  Google Scholar 

  30. Wright, AS (1983). Molecular dosimetry techniques in human risk assessment: an industrial perspective. In Hayes, AW, Schnell, RC and Miya, TS (eds) Developments in the Science and Practice of Toxicology, pp. 311–18. ( Amsterdam: Elsevier )

    Google Scholar 

  31. Farmer, PB, Bailey, E, Lamb, JH and Connors, TA (1980). Approach to the quantitation of alkylated amino acids in haemoglobin by gas chromatography mass spectrometry. Biomed Mass Spectrom, 7, 41–7

    Article  PubMed  CAS  Google Scholar 

  32. Briscoe, WT, Spizizen, J and Tan, EM (1978). Immunological detection of 06-methylguanine in alykylated DNA. Biochemistry, 17, 1896–1901

    Article  PubMed  CAS  Google Scholar 

  33. Rajewsky, MF, Muller, R, Adamkiewicz, J and Drosdziok, W (1980). Immunological detection and quantification of DNA components structurally modified by alkylating carcinogens (ethylnitrosourea). In Pullman, B, Ts’o, POP and Gelboin, H (eds) Carcinogenesis: Fundamental Mechanisms and Environmental Effects, pp. 207–16. ( Dordrecht: Reidel )

    Google Scholar 

  34. Van der Laken, CJ, Hagenaars, AM, Hermsen, G, Kriek, E, Kuipers, AJ, Nagel, J, Scherer, E and Welling, M (1982). Measurement of 06-ethyldeoxyguanosine and N-(deoxy- guanosin-8-yl)-N-acetyl-2-amino-fluorene in DNA by high- sensitive enzyme immunoassays. Carcinogenesis, 5, 569–72

    Article  Google Scholar 

  35. Poirier, MC, Santella, R, Weinstein, IB, Gruberger, D and Yuspa, SH (1980). Quantitation of benzo-a-pyrene-deoxy- guanosine adducts by radio-immunoassay. Cancer Res, 40, 412–16

    PubMed  CAS  Google Scholar 

  36. Poirier, MC, Yuspa, SH, Weinstein, IB and Blobstein, S (1977). Detection of carcinogen-DNA adducts by radioimmunoassay. Nature Lond, 270, 186–8

    Article  PubMed  CAS  Google Scholar 

  37. Bean, RA, Schoen, MA, Zaalberg, OE and Lohman, PM (1982). The detection of DNA damage by immunological techniques. In Sorsa, MH and Vainio, H (eds) Mutagens in Our Environment, pp. 111–24. ( New York: Alan R. Liss )

    Google Scholar 

  38. Bean, RA, Schoen, MA, Zaalberg, OE and Lohman, PM (1982). The detection of DNA damage by immunological techniques. In Sorsa, MH and Vainio, H (eds) Mutagens in Our Environment, pp. 111–24. ( New York: Alan R. Liss )

    Google Scholar 

  39. Poirier, MC (1984). The use of carcinogen-DNA adduct antisera for quantitation and localisation of genomic damage in animal models and the human population. Environ Mutagen, 6, 879–87

    Article  PubMed  CAS  Google Scholar 

  40. Gelboin, HV, Fujino, T, Song, B-J, Park, SS, Cheng, K-C, West, D, Robinson, R, Miller, H and Friedman, FK (1984). Monoclonal antibody-directed phenotyping of cytochromes P- 450 by enzyme inhibition, immunopurification and radioimmunoassays. In Omenn, GS and Gelboin, HV (eds) Genetic Variability in Responses to Chemical Exposure, Banbury Report 16. pp. 65–84. (Cold Spring Harbor Laboratory)

    Google Scholar 

  41. Price-Evans, DA, Mahgoub, A, Sloan, TP, Idle, JR and Smith RL (1980). A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet, 17, 102–10

    Article  Google Scholar 

  42. Distlerath, LM, Larrey, D and Guengerich, FP (1984). Genetic polymorphism of debrisoquine 4-hydroxylation: identification of the defect at the level of a specific cytochrome P-450 in a rat model. In Omenn, GS and Gelboin, HV (eds) Genetic Variability in Responses to Chemical Exposure: Banbury Report 16. pp. 85–96. (Cold Spring Harbor Laboratory)

    Google Scholar 

  43. Mekler, Ph, Delehanty, JT, Lohman, PHM, Brouwer, J, Putte, PvD, Pearson, P, Pouwels, PH and Ramel, C (1985). The use of recombinant DNA technology to study gene alteration; ICPEMC Publication No. 11. Mutation Res (in press)

    Google Scholar 

  44. Cooper, GF and Lane, M-A (1984). Cellular transforming genes and oncogenesis. Biochim Biophys Acta, 738, 9–20

    PubMed  CAS  Google Scholar 

  45. Shih, C, Shilo, BZ, Goldfarb, MP, Dannenberg, A and Wein¬berg, RA (1979). Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci USA, 76, 5714–18

    Article  PubMed  CAS  Google Scholar 

  46. Reddy, EP, Reynolds, RK, Santos, E and Barbacid, M (1982). A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature, Lond, 300, 149–52

    Article  CAS  Google Scholar 

  47. Tabin, CJ, Bradley, SM, Bargmann, CI, Weinberg, RA, Papageorge, AG, Scolnick, EM, Dhar, R, Lowy, DR and Chang EH (1982). Mechanism of activation of a human oncogene. Nature, Lond, 300, 143–9

    Article  CAS  Google Scholar 

  48. Taporowsky, E, Suard, Y, Fasano, O, Shimizu, K, Goldfarb, M and Wigler, M (1982). Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature, Lond, 300, 762–5

    Article  Google Scholar 

  49. Land, H, Parada, LF and Weinberg, RA (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, Lond, 304, 596–602

    Article  CAS  Google Scholar 

  50. Rosenkranz, HS, Klopman, G, Chankong, V, Pet-Edwards, J and Haimes, YY (1984). Prediction of environmental carcinogens: a strategy for the mid-1980s. Environ Mutagen, 6, 231–58

    Article  PubMed  CAS  Google Scholar 

  51. Waters, MD and Auletta, A (1981). The GENE-TOX Program: genetic activity evaluation. J Chem Inf Comput Sci, 21, 35–8

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. J. Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cantab Group, Cambridge, England

    A. N. Worden

  2. Department of Biochemistry, University of Surrey, Guildford, England

    D. V. Parke

  3. Girton College, Cambridge, England

    J. Marks (Director of Medical Studies) (Director of Medical Studies)

Rights and permissions

Reprints and permissions

Copyright information

© 1986 MTP Press Limited

About this chapter

Cite this chapter

Dean, B.J. (1986). Genetic Toxicology Testing. In: Worden, A.N., Parke, D.V., Marks, J. (eds) The Future of Predictive Safety Evaluation. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4139-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4139-7_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8336-2

  • Online ISBN: 978-94-009-4139-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation